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affected more than men; and 2) QOL impacts of obesity
decline with age. Qualitative work during the develop-
ment of the Obesity and Weight Loss Quality-of-Life
Measure (OWLQOL) indicated that these assumptions
may not necessarily be completely valid. We explore 
the degree to which weight-related quality of life varies
between gender and across age groups. METHODS:
Through Knowledge Networks, a web-based TV survey
panel similar to the national population, an adult sample
(age > 20) of 1342 obese persons (BMI >= 30) was
prospectively and randomly selected. Quality of life was
measured by the total summary score and four subdo-
main scores of the OWLQOL. QOL scores were plotted
by age and gender. Analysis of variance was used to
examine the signiﬁcance of the differences between group
means. RESULTS: The greatest disparities in QOL scores
by gender appear in the younger (20–35) age group where
the mean OWLQOL score for males was 82.7, and only
58.4 for females (F = 75.6; P < 0.001). The smallest
gender differences between mean scores was demon-
strated in the oldest (66+) group (87.3 for males and 77.7
for females (F = 11.5; P = 0.001)). When assessing QOL
scores separately by gender, the differences between age
groups are only signiﬁcant within the female group (P <
0.01). CONCLUSIONS: The signiﬁcant differences in
weight-related quality of life (24.3 point difference in the
younger group and 9.6 for the oldest group) tend to be
masked when looking only at combined group totals. Evi-
dence from this data suggests that women are affected dif-
ferently by obesity than men (but more so in the younger
age groups) and that negative QOL impacts from obesity
do lessen with age, but these differences are only signiﬁ-
cantly different for female populations.
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OBJECTIVE: Adults who are overweight or obese are at
greater risk for other serious health conditions and self-
report a variety of negative impacts on quality of life,
including low self-esteem, social stigma and many both-
ersome physical symptoms. This analysis explores the
relationship between symptoms and physically linked
quality-of-life scores with comparisons made between
BMI levels. METHODS: Through Knowledge Networks,
a web-based TV survey panel similar to the national pop-
ulation, an adult sample of 1348 obese persons (BMI 30
or higher) and 1157 persons (BMI less than 30) were
prospectively and randomly selected. Using the newly
developed Weight-Related Symptom Measure (WRSM),
we obtained self-reported data for a list of 20 physical
symptoms. Quality of life was measured by the Obesity
and Weight Loss Quality of Life Measure (OWLQOL).
For each symptom, we identiﬁed the differences in the
physical health subscale of the OWLQOL for those re-
porting and not reporting the symptom and then com-
pared those results between BMI groups. RESULTS: For
all symptoms, there was a signiﬁcant difference in scores
on the physical health subscale of the OWLQOL between
those who reported the symptom (55.9 to 89.7) and those
who did not (73.8 to 95.9), indicating higher quality of
life for those not reporting symptoms. Those reporting
each symptom demonstrated highly signiﬁcant differences
between high (55.9 to 69.2) and low BMI groups (82.5
to 89.7) for physical health related QOL, indicating
higher QOL for those with lower BMI levels. CONCLU-
SIONS: While the physical symptoms that occur fre-
quently in obese populations can also be experienced by
those with low BMI scores, there is a far greater tendency
for them to be reported in individuals with BMI scores
greater than 30, and a signiﬁcantly greater negative
impact of these same symptoms on the QOL of those who
have BMI scores of 30 or more.
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OBJECTIVE: To describe perceived work performance of
patients with the diagnosis of acute coronary syndrome
(ACS) and to determine predictive relationships of several
patient-speciﬁc independent variables. METHODS: All
ACS patients discharged from a university afﬁliated hos-
pital during a 3-year period were mailed a questionnaire
that included the Work Performance Scale (WPS). Inde-
pendent variables included the SF-8 (PCS-8, MCS-8), 
the EQ-5D General Health Visual Analog Scale (VAS),
cardiac functional status [Duke Activity Status Index
(DASI)], symptom count (Symptom Distress Checklist),
comorbidity index (Charlson self-administered), patient-
perceived cardiac disease severity, medication count, 
compliance score, job satisfaction, current employment
duration, patient demographics, and ACS type [unstable
angina (UA) or myocardial infarction (MI)]. This analy-
sis includes respondents who indicated current employ-
ment. Stepwise-elimination (p < 0.05) linear regression
models determined the combined predictive ability of
independent variables on WPS. Due to the high correla-
tion between the PCS-8, VAS, and DASI, three separate
models were used with each one as a predictor variable.
RESULTS: To date, 414 of 1230 patients (34%) have
responded, including 122 (29.5%) currently working.
Current workers averaged 57.6(±8.6) years of age; 80.3%
male; 94.3% Caucasian; 69.2% history of MI; 13.4%
severe or worse perceived cardiac disease severity.
Respondents reported the following mean(s.d.) responses:
DASI 26.0(±7.4); comorbidity index 1.7(±1.4); medica-
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tions 7.2(±4.1); compliance score 4.8(±0.6); symptoms
6.2(±4.4); PCS-8 59.2(±7.9); MCS-8 51.2(±8.1); and VAS
82.4(±16.0). The mean WPS was 4.6(±0.5); mean
employment duration of 14.6(±12.3) years and 2.5%
reporting job dissatisfaction. Of the 3 models tested, that
with the highest explanatory ability (r-square = 0.36)
included number of symptoms, age, perceived cardiac
severity, and PCS-8, with more symptoms, higher per-
ceived severity, higher age, and lower PCS-8 scores 
associated with lower perceived work performance.
CONCLUSIONS: Currently employed ACS patients
report a high level of work performance. Symptomology,
perceived disease severity, age, and physical function
appear to be associated with work performance.
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OBJECTIVE: To model the predictive relationships of
self-reported patient-speciﬁc, independent predictor vari-
ables on dependent health-related quality of life measures
(HRQL) in an acute coronary syndrome (ACS) popula-
tion. METHODS: All ACS patients discharged from a
university afﬁliated hospital during a 3-year period were
mailed a questionnaire that included two short general
HRQL measures, the SF-8 and EQ-5D. Independent vari-
ables included cardiac functional status [Duke Activity
Status Index (DASI)], symptom count (Symptom Distress
Checklist), comorbidity index (Charlson self-adminis-
tered), patient-perceived cardiac disease severity, medica-
tion count, compliance score, patient demographics, and
ACS type [unstable angina (UA) or myocardial infarction
(MI)]. Three separate stepwise-elimination (p < 0.05)
linear regression models determined the combined pre-
dictive ability of independent variables on the PCS-8, the
MCS-8, and the EQ-5D General Health Visual Analog
Scale (VAS). RESULTS: To date, 414 of 1230 patients
(34%) have responded. The mean (±s.d.) age was
65.7(±11.3) years; 67.7% male; 94.0% Caucasian;
62.1% history of MI; and 22.9% reported severe or
worse cardiac disease severity. Respondents reported 
the following mean (±s.d.) responses: DASI 20.5(±8.1);
comorbidity index 2.5(±1.9); number of medications
8.4(±4.6); compliance score 4.8(±0.5); number of symp-
toms 7.8(±4.9); PCS-8 53.7(±10.5); MCS-8 49.5(±9.5);
and VAS 73.6(±20.5). The ﬁnal PCS model had an r-
square of 0.51 and contained the comorbidity index,
number of symptoms, age, gender, perceived cardiac
severity, household income, and type of ASC. The ﬁnal
MCS-8 model had an r-square of 0.36 and contained
number of symptoms, perceived cardiac severity, and
education level. The ﬁnal VAS model had an r-square of
0.49 and contained comorbidity index, number of symp-
toms, perceived cardiac severity, and household income
level. CONCLUSIONS: Patient self-reported measures 
of disease, cardiac functional status, symptomology, and
medication utilization formed highly predictive models 
of HRQL. Greater numbers of reported symptoms and
higher patient-perceived cardiac severity were associated
with lower HRQL in all three models.
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OBJECTIVE: The ﬁve statins currently available in the
US (atorvastatin [A], pravastatin [P], simvastatin [S], ﬂu-
vastatin [F] and lovastatin [L]) differ in terms of their 
abilities to lower LDL-C, the need to adjust dosing for
decreased renal function, potential for drug-drug interac-
tions, cost, recommended hepatic function monitoring
schedule, and level of proven effectiveness. The implica-
tions of these differences on the clinical use of statins have
been largely unexplored. The purpose of this study was
to examine the effects of these intra-class differences 
on clinical decision making using multicriteria decision
analysis. METHODS: A multicriteria decision analysis
using the Analytic Hierarchy Process (AHP) was per-
formed from the practitioner’s perspective. The goal was
deﬁned as “Choose the best statin”. Decision criteria were
based on the differences mentioned above. Costs were
included in the analysis both as internet drug store prices
(scenario 1) and in terms of patient co-pays for 3 current
three-tiered managed care formularies in Rochester, NY
(scenarios 2,3, & 4). Data comparing the statins’ perfor-
mance on the other criteria were obtained from the liter-
ature. RESULTS: Statin priority scores, which measure
the relative rankings of the alternatives’ abilities to meet
the all decision criteria (higher scores are better), for the
4 scenarios are: Scenario 1: L = 0.214, F = 0.209, P =
0.200, S = 0.190, A = 0.187; Scenario 2: P = 0.209, L =
0.208, S = 0.205, F = 0.192, A = 0.188; Scenario 3: 
P = 0.213, L = 0.208, S = 0.200, A = 0.192, F = 0.187;
Scenario 4: P = 0.209, L = 0.208, S = 0.205, A = 0.192,
F = 0.187. In addition to cost, relative priority scores in
all scenarios were affected by differences in the impor-
tance assigned to ability to lower LDL-C, ease of pre-
scribing safely, and proven effectiveness. CONCLUSION:
The relative importance of differences among statins has
a signiﬁcant impact on optimal clinical use of these drugs.
These results suggest that practitioners should be aware
of these differences and incorporate them in clinical deci-
sions regarding statin prescriptions.
